Also from this source

You just read:

Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting

News provided by

Esperance Pharmaceuticals, Inc.

Jun 01, 2015, 07:30 ET